Deciphera Pharmaceuticals, Inc. Lease, Cost
Deciphera Pharmaceuticals, Inc. reported Lease, Cost of $4.88 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. lease, cost for the quarter ending 2020-12-31 was $1.46M, a 32.61% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. lease, cost for the quarter ending 2020-09-30 was $1.48M, a 372.29% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. lease, cost for the quarter ending 2019-12-31 was $1.10M.
- Deciphera Pharmaceuticals, Inc. lease, cost for the quarter ending 2019-09-30 was $314.00K.
- Deciphera Pharmaceuticals, Inc. lease, cost for fiscal 2023 was $4.88M, a 18.55% decline from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. lease, cost for fiscal 2022 was $6.00M, a 11.30% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. lease, cost for fiscal 2021 was $6.76M, a 35.69% increase from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. lease, cost for fiscal 2020 was $4.98M, a 129.59% increase from fiscal 2019.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $4.88M 10-K · filed 2024-02-07 | |||
| 2022-12-31 | $6.00M 10-K · filed 2024-02-07 | |||
| 2021-12-31 | $6.76M 10-K · filed 2024-02-07 | |||
| 2020-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $2.94M derived: sum of 2 quarters · filed 2023-02-07 | $4.98M 10-K · filed 2023-02-07 | |
| 2020-09-30 | $1.48M 10-Q · filed 2020-11-05 | $3.52M 10-Q · filed 2020-11-05 | ||
| 2019-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $1.42M derived: sum of 2 quarters · filed 2022-02-08 | $1.83M derived: sum of 3 quarters · filed 2022-02-08 | $2.17M 10-K · filed 2022-02-08 |
| 2019-09-30 | $314.00K 10-Q · filed 2020-11-05 | $728.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.07M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $414.00K 10-Q · filed 2019-08-02 | $755.00K 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $341.00K 10-Q · filed 2019-05-09 |